The ultrasound contrast agent for use in HyCoSy procedures is instrumental in detecting potential reasons for infertility associated with fallopian tube blockages or uterine abnormalities. Credit: ...
MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical ...
Bracco Imaging, a global leader in diagnostic imaging, announced that its ultrasound contrast agent SonoVue has been approved by the China's National Medical Products Administration (NMPA) for use in ...
WASHINGTON, UK (26 February, 2025) - Rocket Medical Plc recently launched the HyView HSG and HyCoSy Catheter. The device was developed for use in hysterosalpingography (HSG) and Hysterosalpingo ...
Assessment of tubal patency remains a cornerstone of female fertility evaluation, as tubal obstruction accounts for up to 30–40 per cent of infertility cases worldwide. Historically, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results